Aranjuez

Ercros' pharmaceuticals division's headquarters and production centre

Over 75 years of expertise serving the pharmaceutical industry

The Aranjuez plant (Madrid) has a long-standing history in the pharmaceutical industry. Since its beginnings in penicillin production, it has developed extensive expertise in the manufacture of active pharmaceutical ingredients (APIs), particularly antibiotics, using fermentation and chemical synthesis technologies.

Today, the plant combines the production of generic APIs with a growing focus on contract development and manufacturing (CDMO), offering tailored solutions to the pharmaceutical industry.

The plant has three multipurpose synthesis and fermentation production units, a facility for the production and blending of sterile products, and a laboratory and R&D centre. These facilities, together with its technical and regulatory expertise, enable the plant to undertake projects involving process development, technology transfer, industrial scale-up, and the manufacture of active pharmaceutical ingredients and pharmaceutical intermediates.

Ercros is the world's second-largest producer of fusidic acid and the third-largest producer of fosfomycin. Its product portfolio also includes macrolide antibiotics, antiulcer agents, antihypertensives and antifungals.

With a workforce of 230 employees and an annual production capacity of approximately 430,000 kg, the Aranjuez plant exports 95% of its output to international markets, primarily the European Union, the United States, the Middle East and North Africa.
 

Main street of the Aranjuez factory
Multi-purpose synthesis plant at the Aranjuez factory
Fermenters at the Aranjuez factory
Industrial fermentation towers at the Aranjuez factory
Night view of the Aranjuez factory
Night view of the multi-purpose synthesis plant and the solvent warehouse
Financial year 2024

In figures

The key figures of the Aranjuez factory

230

Workforce

430,000 kg

Annual production capacity

95%

Exports

1st

Company manufacturing antibiotics in Spain

A bit of history

Instalaciones de la fábrica de Aranjuez en 1949
1949

Compañía Española de Penicilicilina y Antibióticos (Cepa) in collaboration with the American company Merck & Co. Inc. wins a tender called by the Spanish government to develop a national antibiotics industry and becomes the first company to manufacture penicillin in Spain.

Laboratorio de la fábrica de Aranjuez en 1951
1951

Inauguration of the Aranjuez factory, under the ownership of Cepa, with the most advanced equipment and processes. Its production capacity is 1.5 million vials of crystallised sodium penicillin per month.

Interior de una planta de la fábrica de Aranjuez en 1952
1952

After several expansions of its facilities, the initial production of penicillin is doubled to meet the needs of the Spanish market.

Laboratorio de la fábrica de Aranjuez en 1968
1968

Cepa, together with Merck, is developing a new antibiotic, fosfomycin, a market in which the Aranjuez factory will be one of the world leaders.

Folleto comercial de CEPA
1971

Start of industrial-scale production of fosfomycin and, two years later, of a new antibiotic, erythromycin.

Construcción de fermentadores de la fábrica de Aranjuez en 1975
1974

Cepa is acquired by Unión Explosivos Río Tinto, S.A. (ERT), the predecessor of Ercros.

Pilot plant at the Aranjuez factory in 1990
1990

As a result of the merger of ERT and S.A. Cros to form Ercros, Cepa is split into two companies. One of them, Fermentaciones y Síntesis Españolas, S.A. (Fyse), retains the API manufacturing and the Aranjuez factory facilities and joins Ercros.

Laboratorio de la fábrica de Aranjuez
1997

Industrial-scale production of the erythromycin derivatives, azithromycin and clarithromycin, begins.

Fermentation plant in Aranjuez
2000

Commercialisation of fusidic acid begins.

Lateral de la planta de síntesis de la fábrica de Aranjuez
2004

A new multi-purpose plant is commissioned to manufacture synthesis products. This considerably increases the centre's production volume.

Bidones de fosfomicina trometramol
2009

Industrial production of fosfomycin trometamol begins.

Persona trabajando en la planta estéril de la fábrica de Aranjuez
2012

Inauguration of a sterile product mixing and packaging plant.

Planta de productos estériles de Aranjuez
2017

Expansion of the fermentation capacity and the synthetic products plant. A new sterile products plant is commissioned to replace the existing one.

75th anniversary of the Aranjuez factory
2024

Celebration of the 75th anniversary and inauguration of the new extraction plant, with an annual production capacity of 150,000 kilos.

Photo gallery of the factory's 75th anniversary

75th anniversary of the Aranjuez factory
75th anniversary of the Aranjuez factory
75th anniversary of the Aranjuez factory
75th anniversary of the Aranjuez factory
75th anniversary of the Aranjuez factory
75th anniversary of the Aranjuez factory
75th anniversary of the Aranjuez factory
75th anniversary of the Aranjuez factory
75th anniversary of the Aranjuez factory
75th anniversary of the Aranjuez factory

Certificates of the Aranjuez factory

The distinctive marks that endorse this factory's commitment to sustainability.

Contact the factory

If you would like to visit or contact us, you can start here.

All the fields are mandatory.
Address

Paseo del Deleite, s/n
28300 Aranjuez (Madrid)
Tel: +34 918 090 340
Email: aranjuez@ercros.es